|Written by Rob Goldman|
Big stocks reached new highs and small stocks tanked last week. Meanwhile, the advent of the fall season, and questions over whether Alibaba's (NASDAQ – BABA) magic will continue, should be front and center this week. So what do you do? Simple. Follow our A to Z Investing Ideas.
INVESTING TODAY FROM A TO Z
So, what does it mean when the NASDAQ Composite is up 10% for the year, the Dow Jones Industrial Average is up less than half that at 4.2% and the Russell 2000 is down nearly 2%? To put it simply, big cap tech and health care stocks are on fire, mega caps are looking good and small caps suck.
Investors today are like drug addicts or gamblers. Their appetite for stories spun by the likes of Apple (NASDAQ—AAPL) and Alibaba (NYSE—BABA) outweighs valuation concerns and fears that they miss the rise. Plus, with small caps in the toilet, where else to put your money but in the same place as the herd?
Sure, big caps may continue to be the place to be, but small caps will have their day, albeit not for another several weeks, by our estimation. Meanwhile, the autumnal equinox begins Tuesday (the beginning of the fall season), the Jewish New Year begins Wednesday evening (which means lighter volume Thursday) and quarterly portfolio reconstruction is complete. So, will stocks “fall with this seasonality”, especially since so many are at nosebleed levels? What do you do?
Here is our near term investing formula from A to Z.
A- Apple truly is a beast. Very hard to bet against it. Too pricey? Trade options.
B- As in BABA, Alibaba. This is the latest favorite son/craze. Pass, until research reports are released. There are skeletons here.
C- Car stocks. They aren’t very expensive and though people are not buying homes they are buying cars.
D- Don’t feel compelled to be fully invested. It is okay to sit on some cash. In fact, it may prove to be prudent.
E- As in eBay (NASDAQ—EBAY). We still believe that a PayPal spin-off could be lucrative.
F- Facebook (NASDAQ—FB) is enjoying great mobile growth. Continue your postings but investing in it right now may not be best for your timeline.
G- Is there anything Google (NASDAQ—GOOG) doesn’t want to do? It is getting scary. Still, it seems that it can overcome all barriers.
H- Health care stocks benefit from perceived safety in potentially down markets. Investors seem to have forgotten all about Obamacare and so should you. Until you should.
I- iShares remains the most popular family of ETFs. If you are going to stay fully invested, make sure ETFs represent the core of your portfolio.
J- JC Penney (NYSE—JCP) isn’t going out of business like RadioShack (NYSE—RSH). But the stock isn't going up, either.
K- Burger King (NYSE—BKW) has made a black burger for the Japanese market. Either they are sly like a fox or they have lost their f**king minds. I think this move is in the red.
L- Lockheed Martin (NYSE—LMT) is the country’s biggest aerospace/defense company. If the Scarecrow from The Wizard of Oz was President, he would not stand for this ISIS crap, or the nonsense China, North Korea, and the fly-bys in which Russia has engaged recently. Regardless, this is the go-to defense stock, if you believe we will fight them with something more potent than putting the NFL’s domestic violence abusers on the front line.
M- You know McDonald’s (NYSE—MCD) is in trouble when they admit that their former spin-off, Chipotle (NYSE—CMG) understands the fast-casual market while they endure declining sales. Higher beef prices can’t help and the fast-casual dining space in general looks tasty.
N- Nanotechnology was a huge buzzword about 10 years ago. What happened? It is a stark reminder that the next big industry is usually just the next big PR play and while the stocks in the space move markedly higher, it only lasts for a little while.
O- Oil stocks have had a rough go of it. Has the U.S. leadership story played itself out? Don’t count out this group just yet—-especially given the current volatile and fragile geopolitical environment.
P- Pandora (NYSE—P), Pfizer (NYSE—PFE), Priceline.com (NASDAQ—PCLN), Hewlett-Packard (NYSE—HPQ). Is it me or does America just love these stocks?
Q- The “triple Q’s” have been great so far. Just like baseball season, there are more games to play, but the season will come to a close in late October.
R- “Reefer stocks” have been woefully out of favor after the insane run early in the season. Those who understand the correlation between policy, politics, and business will see how the outcome of the midterm elections state ballots can rejuvenate the space.
S- Small stocks typically rule in the fourth quarter. It may be too early to start buying. However, its time will come again, sooner than you think.
T- Tesla Motors’ (NASDAQ—TSLA) CEO made unusual comments regarding his stock’s lofty valuation. I commend him for that. We think this popular stock, along with its options, are also attractive only on dips.
U- United Parcel Service (NYSE—UPS) will be strong again in Q4 as online holiday sales are synonymous with UPS shipping.
V- Aside from its moves in August, Vick’s Cough Syrup has gotten more action than the VIX. Volume was big last week for a change but we need both to help the broader market, not just the major holdings in key indices.
W- Wells Fargo (NYSE—WFC) is a maligned bank but appears to be well-positioned to benefit from the economy and Bank of America’s (NYSE—BAC) issues.
X- If you are a believer in the economy, particularly in basic industries, U.S. Steel (NYSE—X) is an oldie but a goodie.
Y- Alibaba may be getting all the love but there is another foreign technology company not to be overlooked called Yandex (NASDAQ—YNDX).
Z- Zoe’s Kitchen (NASDAQ—ZOES) might be a great chain enjoying a major growth phase but the valuation seems pricey.
Have a great week!
Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, unless noted, With rare exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ. Goldman Small Cap Research members and contributors' bios, certifications, and experience can be found on our website: www.goldmanresearch.com .
This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces non-sponsored and sponsored (paid) investment research. Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
The Firm's non-sponsored research publications category, Select Research, reflects the Firm's internally generated stock ideas, along with economic, industry and market outlooks. In virtually all cases, stocks mentioned in Select Research offerings are listed on the NYSE or the NASDAQ. Publications in this category include the weekly newsletter The Goldman Guide, daily Market Monitor blogs, Special Reports, and premium products such as The 30-30 Report. Goldman Small Cap Research analysts are neither long nor short stocks mentioned in this newsletter.
Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored micro cap research ideas that typically carry greater risks than those stocks covered in Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company's individual disclosures for each engagement, which can be found in company-specific Opportunity Research reports, updates and articles.
Goldman Small Cap Research has not been compensated for any content in this issue.
All information contained in this newsletter and in our reports were provided by the companies mentioned via news releases, filings, and their websites or generated from our own due diligence. Economic, market data and charts are provided by a variety of sources and are cited upon publication. Stock performance data is derived from Yahoo! Finance. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, other firms, or other financial news outlets. Goldman Small Cap Research relied solely upon information provided by companies through filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, blog, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This newsletter does not provide all information material to an investor's decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS REPORT OR NEWSLETTER IS PROVIDED "AS IS" WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com.